2021 Jon A. Kaswick, MD

Urology Virtual

Symposium
 

October 8 - 9, 2021

WELCOME!

A Message from the Symposium Co-chairs and Planning Committee

Please join us for the 2021 Jon A. Kaswick, MD Urology Virtual Symposium featuring an exceptional two-day program packed with distinguished guest lecturers. The planning committee has arranged a series of virtual presentations designed to provide relevant, up-to-date information that strive to address your clinical and educational goals. 

Benefits of attending 2021 Urology Symposium:

  • Evaluation and management of male LUTS
  • Newest laser and minimally invasive surgical options for treating BPH
  • Future of telehealth and its application in Urologic practice
  • Prostate Cancer Surveillance and use of biomarkers and MRI and nuclear imaging
  • Management of both large and small renal masses in the era of Immunotherapy
  • Update on Kaiser Permanente’s Surgical Quality and Volume Initiative

Our goal is to provide the latest Urologic data and evidence that will advance your knowledge and understanding of these disease processes and help integrate this into your daily practice. 

The virtual symposium will provide an opportunity for our Kaiser Permanente Urology community to reconnect, network, and collaborate during this two-day virtual event.

Given the events of the past year that have limited our ability to meet in person, we look forward to having an opportunity to strengthen our Kaiser Permanente Urology community with comradery, knowledge, and expertise.
 
We warmly encourage you to attend and be a part of this fantastic program!

Sincerely,
Stacey C. Carter, MD and Mehrdad Alemozaffar, MD
 

LEARNING OBJECTIVES


At the end of this activity, learners will be able to:

  • Increase the delivery of high-quality telemedicine services to drive value-based urology
  • Evaluate SCPMG data on same day TURP and evaluate best practice patterns of high-volume surgeons to improve on readmissions/complications
  • Evaluate and manage male lower urinary tract symptoms (BPH / OAB)
  • Determine treatment options for small renal masses and the role of cytoreductive nephrectomy
  • Determine how newer laser technologies impact procedures for treatment planning
  • Utilize advanced imaging with Nuclear modalities for evaluation of metastasis in prostate cancer patients


ACCREDITATION STATEMENT

Physicians - The Southern California Permanente Medical Group is accredited by the California Medical Association (CMA) to provide continuing medical education for physicians.
 

CREDIT DESIGNATION STATEMENT

The Southern California Permanente Medical Group designates this live educational activity for a maximum of 8.0 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses and Physician Assistants – Attendees may report up to 8.0 hours toward continuing education requirements for license renewal. ‘CME’ can be written in lieu of the provider number on all licensure renewal applications.

Friday: 4 hours
Saturday: 4 hours


TARGET AUDIENCE

  • SCPMG Urologists
  • Primary Urology nurses, medical oncologists, radiation oncologists, gynecologists, family practitioners, transplant surgeons, transplant nephrologists, community urologists, general surgeons, and healthcare administrators